Neuland Laboratories Limited, a prominent pharmaceutical manufacturer, has reported a total income of ₹2053.1 crore for the financial year ending March 31, 2026. The company’s EBITDA for the same period stood at ₹603.4 crore.
The Hyderabad-based company, known for its active pharmaceutical ingredients (APIs) and custom manufacturing solutions, shared its financial results, highlighting a significant growth trajectory. The total income for Q4FY26 was reported at ₹788.7 crore, marking a 134.9% increase year-on-year from ₹335.8 crore in Q4FY25. The EBITDA for Q4FY26 surged by 448.6% to ₹319.4 crore from ₹58.2 crore in the previous year.
The EBITDA margin for the quarter was 40.5%, a substantial improvement of 2316 basis points compared to the previous year’s 17.3%. Profit Before Tax (PBT) for Q4FY26 was ₹287.0 crore, reflecting a 636.6% increase from ₹39.0 crore in Q4FY25. The PBT margin also saw a remarkable rise, reaching 36.4% compared to 11.6% in the previous year.
Profit After Tax (PAT) for the quarter was ₹212.5 crore, a 666.3% increase from ₹27.7 crore in Q4FY25. The company attributed its robust performance to strong business visibility anchored by commercial and near-commercial molecules.
Saharsh Davuluri, CEO and Managing Director of Neuland Laboratories, expressed satisfaction with the company’s performance, stating, “We are pleased with the fact that we have ended FY26 on a strong note in line with our original expectations. There is good business visibility in the short to medium term anchored by commercial and near-commercial molecules.”
Neuland Laboratories is also investing in future growth, focusing on peptide manufacturing and a new R&D centre. These initiatives are part of the company’s strategy to ensure sustainable growth.
The company will hold an earnings call at 17:30 IST on May 12, 2026, to discuss its performance and answer questions from participants. The transcript of the call will be available on the company’s website.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).